A matter of life and cell death.
暂无分享,去创建一个
[1] A. Levine,et al. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.
[2] B. Stillman,et al. Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins , 1987, Journal of virology.
[3] M. Noble,et al. Ras‐mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. , 1988, The EMBO journal.
[4] H. Ruley,et al. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Ohlsson,et al. Insulin‐like growth factor 2 and short‐range stimulatory loops in control of human placental growth. , 1989, The EMBO journal.
[6] A. Strasser,et al. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.
[7] W. Brown,et al. Structure and polymorphism of human telomere-associated DNA , 1990, Cell.
[8] J. Nevins,et al. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. , 1991, Genes & development.
[9] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.
[10] P. Duerksen-Hughes,et al. The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells , 1991, Journal of virology.
[11] G. Hicks,et al. Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest , 1991, Molecular and cellular biology.
[12] S. Korsmeyer,et al. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Weinberg,et al. Effects of an Rb mutation in the mouse , 1992, Nature.
[14] D. Green,et al. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. , 1992, Science.
[15] Yi-Song Wang,et al. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[16] Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. , 1993, Molecular and cellular biology.
[17] G. Evan,et al. The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.
[18] S. Lowe,et al. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.
[19] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[20] Yi-Song Wang,et al. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. , 1993, Oncogene.
[21] A. Levine,et al. p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. , 1994, Genes & development.
[23] G. Evan,et al. Oncogenes and cell death. , 1994, Current opinion in genetics & development.
[24] H. Hermeking,et al. Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.
[25] H. Pan,et al. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.
[26] K. Alitalo,et al. c‐Myc induces cellular susceptibility to the cytotoxic action of TNF‐alpha. , 1994, The EMBO journal.
[27] G. Evan,et al. c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.
[28] John Calvin Reed,et al. Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.
[29] Stephen S. Gisselbrecht,et al. Activation of cyclin A-dependent protein kinases during apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] E. White,et al. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells , 1994, Journal of virology.
[31] K. Dameron,et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.
[32] M. Karin,et al. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.
[33] S. Estus,et al. Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death , 1994, Neuron.
[34] P. O'Connor,et al. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. , 1994, Oncogene.
[35] G. Wahl,et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.
[36] M. Collins,et al. Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation. , 1994, Oncogene.
[37] R. DePinho,et al. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens , 1994, Nature.
[38] S. Bayley,et al. Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. , 1994, Oncogene.
[39] N. Hay,et al. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.
[40] D. Campana,et al. Copyright � 1995, American Society for Microbiology PITSLRE Protein Kinase Activity Is Associated with Apoptosis , 1994 .
[41] S. Velasco-Miguel,et al. Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.
[42] J. Cleveland,et al. The role of ornithine decarboxylase in c-Myc-induced apoptosis. , 1995, Current topics in microbiology and immunology.
[43] J. Martinou,et al. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation , 1995, The Journal of cell biology.
[44] V. Metelev,et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.
[45] G. Prendergast,et al. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. , 1995, Oncogene.
[46] A. Levine,et al. Essential role for p53-mediated transcription in E1A-induced apoptosis. , 1995, Genes & development.
[47] E. White,et al. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein , 1995, Molecular and cellular biology.
[48] J. Roth,et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.
[49] M. Israel,et al. Inhibition of apoptosis by the retinoblastoma gene product. , 1995, The EMBO journal.
[50] D. Lane,et al. p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts. , 1995, Oncogene.
[51] L. Donehower,et al. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. , 1995, Oncogene.
[52] Q. Dou,et al. Failure to activate interleukin 1β‐converting enzyme‐like proteases and to cleave retinoblastoma protein in drug‐resistant cells , 1996, FEBS letters.
[53] G. Gil-Gómez,et al. Bax alpha perturbs T cell development and affects cell cycle entry of T cells. , 1996, The EMBO journal.
[54] J. Acker,et al. Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex. , 1996, The EMBO journal.
[55] G. Wahl,et al. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.
[56] P. Branton,et al. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. , 1996, Oncogene.
[57] A. Braithwaite,et al. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras. , 1996, Oncogene.
[58] C. Prives,et al. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis , 1996, Molecular and cellular biology.
[59] T. Jacks,et al. Targeted disruption of p107: functional overlap between p107 and Rb. , 1996, Genes & development.
[60] T. Jacks,et al. Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1 , 1996, Cell.
[61] A. Porter,et al. Specific cleavage of the retinoblastoma protein by an ICE‐like protease in apoptosis. , 1996, The EMBO journal.
[62] D. Baltimore,et al. Dual roles of ATM in the cellular response to radiation and in cell growth control. , 1996, Genes & development.
[63] A. Strasser,et al. The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry. , 1996, The EMBO journal.
[64] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[65] D. Beach,et al. Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.
[66] W. Lee,et al. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[67] C. Sherr. Cancer Cell Cycles , 1996, Science.
[68] T. Graeber,et al. Modulation of c-Myc activity and apoptosis in vivo. , 1996, Cancer research.
[69] W. Kaelin,et al. The cellular effects of E2F overexpression. , 1996, Current topics in microbiology and immunology.
[70] G. Linette,et al. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[71] T. Hermiston,et al. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis , 1996, Journal of virology.
[72] P. Fallon,et al. Retinoblastoma protein inhibits IFN-gamma induced apoptosis. , 1996, Oncogene.
[73] K. Walsh,et al. Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation , 1996, Science.
[74] M. Greenberg,et al. E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation , 1996, Cell.
[75] W. Ansorge,et al. Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. , 1996, The EMBO journal.
[76] E. White,et al. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. , 1996, Genes & development.
[77] J. Nevins,et al. Distinct roles for E2F proteins in cell growth control and apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[78] N. Hay,et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. , 1997, Genes & development.
[79] N. Dyson,et al. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. , 1997, Genes & development.
[80] A. Klippel,et al. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.
[81] R. Baserga,et al. The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal , 1997, Molecular and cellular biology.
[82] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[83] S. Fulda,et al. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells , 1997, Leukemia.
[84] P. Galle,et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. , 1997, The Journal of clinical investigation.
[85] K. Hunt,et al. P53 Carcinoma Cell Lines and Does Not Require Factor E2f-1 Induces Apoptosis in Human Breast and Ovarian Adenovirus-mediated Overexpression of the Transcription Updated Version Citing Articles E-mail Alerts Adenovirus-mediated Overexpression of the Transcription Factor E2f-1 Induces Apoptosis in Hum , 2013 .
[86] C. Dionne,et al. p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc. , 1997, Cancer research.
[87] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[88] S. Lowe,et al. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[89] Yusuke Nakamura,et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis , 1997, Oncogene.
[90] G. Evan,et al. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. , 1997, Science.
[91] Seamus J. Martin,et al. Degradation of Retinoblastoma Protein in Tumor Necrosis Factor- and CD95-induced Cell Death* , 1997, The Journal of Biological Chemistry.
[92] A. Sarasin,et al. Human cancer and DNA repair-deficient diseases. , 1997, Cancer detection and prevention.
[93] A. Lloyd,et al. Cooperating oncogenes converge to regulate cyclin/cdk complexes. , 1997, Genes & development.
[94] D. Kirn,et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents , 1997, Nature Medicine.
[95] M. Capogrossi,et al. p53 Induces myocyte apoptosis via the activation of the renin-angiotensin system. , 1997, Experimental cell research.
[96] M. Oren,et al. p53; from inductive signal to cellular effect. , 1997, Current opinion in genetics & development.
[97] S. Korsmeyer,et al. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[98] I. Herr,et al. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. , 1997, Cancer research.
[99] Yi-Te Hsu,et al. Movement of Bax from the Cytosol to Mitochondria during Apoptosis , 1997, The Journal of cell biology.
[100] I. Herr,et al. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). , 1997, Blood.
[101] L. Truong,et al. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. , 1997, The Journal of clinical investigation.
[102] P. Cohen,et al. Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[103] J. Turchi,et al. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. , 1997, Cancer research.
[104] D. Hunting,et al. The apoptotic and transcriptional transactivation activities of p53 can be dissociated. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[105] Y. Sun,et al. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter , 1997, Molecular and cellular biology.
[106] L. Peso,et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.
[107] Philip R. Cohen,et al. Further evidence that the inhibition of glycogen synthase kinase‐3β by IGF‐1 is mediated by PDK1/PKB‐induced phosphorylation of Ser‐9 and not by dephosphorylation of Tyr‐216 , 1997, FEBS letters.
[108] K. Helin,et al. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. , 1997, Genes & development.
[109] Daniel E. Johnson,et al. Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family , 1997, Journal of cellular biochemistry.
[110] Y. Lazebnik,et al. Oncogene-dependent apoptosis in extracts from drug-resistant cells. , 1997, Genes & development.
[111] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[112] A. Strasser,et al. The anti‐apoptosis function of Bcl‐2 can be genetically separated from its inhibitory effect on cell cycle entry , 1997, The EMBO journal.
[113] D. Haber,et al. Splicing into Senescence: The Curious Case of p16 and p19ARF , 1997, Cell.
[114] Q. Dou,et al. Characterization of interior cleavage of retinoblastoma protein in apoptosis , 1997, Journal of cellular biochemistry.
[115] B. Vojtesek,et al. Up‐regulation of Fas (CD95) in human p53wild‐type cancer cells treated with ionizing radiation , 1997, International journal of cancer.
[116] V. D’Agati,et al. C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent , 1997, The Journal of experimental medicine.
[117] S. Korsmeyer,et al. Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.
[118] Xiaodong Wang,et al. Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.
[119] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[120] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[121] J. Flint,et al. Viral transactivating proteins. , 1997, Annual review of genetics.
[122] A. Strasser,et al. Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. , 1997, Journal of immunology.
[123] J. Cleveland,et al. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis , 1997, Molecular and cellular biology.
[124] G. Evan,et al. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice , 1998, Current Biology.
[125] D. Goeddel,et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.
[126] J. Nevins,et al. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[127] N. Kabra,et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.
[128] Kenneth G. C. Smith,et al. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes , 1998, The EMBO journal.
[129] D. Green,et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.
[130] L. Ellis,et al. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. , 1998, Cancer research.
[131] Thomas A. Luger,et al. Ultraviolet Light Induces Apoptosis via Direct Activation of CD95 (Fas/APO-1) Independently of Its Ligand CD95L , 1998, The Journal of cell biology.
[132] T. Jacks,et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice , 1998, Nature Genetics.
[133] C. Dang,et al. A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[134] S. Jackson,et al. DNA-dependent protein kinase. , 1997, The international journal of biochemistry & cell biology.